CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 1152680-1152847 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T50665","span":{"begin":0,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Additionally, SDF1 Alpha (20 nM) and/or Fractalkine 20 nM) treatments were added either in the absence or in the presence of gp120 in the serum-free (N2.1 supplement)."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T2514","span":{"begin":0,"end":167},"obj":"Epistemic_statement"}],"text":"Additionally, SDF1 Alpha (20 nM) and/or Fractalkine 20 nM) treatments were added either in the absence or in the presence of gp120 in the serum-free (N2.1 supplement)."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T117","span":{"begin":0,"end":167},"obj":"Sentence"}],"text":"Additionally, SDF1 Alpha (20 nM) and/or Fractalkine 20 nM) treatments were added either in the absence or in the presence of gp120 in the serum-free (N2.1 supplement)."}

    CORD-19-PD-UBERON

    {"project":"CORD-19-PD-UBERON","denotations":[{"id":"T4695","span":{"begin":138,"end":143},"obj":"Body_part"}],"attributes":[{"id":"A4695","pred":"uberon_id","subj":"T4695","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Additionally, SDF1 Alpha (20 nM) and/or Fractalkine 20 nM) treatments were added either in the absence or in the presence of gp120 in the serum-free (N2.1 supplement)."}